EASL–EORTC Clinical Practice Guidelines: …
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver⇑, European Organisation for Research and Treatment of Cancer
Download EASL–EORTC Clinical Practice Guidelines: …
Information
Domain:
Source:
Link to this page:
Documents from same domain
EASL 2017 Clinical Practice Guidelines on the …
www.easl.euEASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infectionq European Association for the Study of the Liver⇑ Summary Hepatitis B virus (HBV) infection remains a global public health
EASL Recommendations on Treatment of Hepatitis …
www.easl.eu1 JOURNAL OF HEPATOLOGY SEPTEMBER 2016 EASL Recommendations on Treatment of Hepatitis C 2016 SUMMARY European Association for the Study of the Liver
EASL Clinical Practical Guidelines on the …
www.easl.euEASL Clinical Practical Guidelines on the management of acute (fulminant) liver failureq European Association for the Study of the Liver⇑ Summary The term acute liver failure (ALF) is frequently applied as a gen-
EASL Clinical Practice Guidelines for the …
www.easl.euEASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosisq European Association for the Study of the Liver⇑ Summary
EASL Recommendations on Treatment of Hepatitis …
www.easl.euEASL Recommendations on Treatment of Hepatitis C 2016q European Association for the Study of the Liver⇑ Introduction Hepatitis C …
EASL Clinical Practice Guidelines: Management of ...
www.easl.euEASL Clinical Practice Guidelines: Management of cholestatic liver diseases European Association for the Study of the Liver* Keywords: Primary biliary cirrhosis; Primary sclerosing cholangitis; Overlap syndrome; Immunoglobulin G4-associated
NUTRITION IN LIVER DISEASE - European …
www.easl.eu4 Programme Abstracts Nutrition in Liver Disease WELCOME MESSAGE Dear Colleagues, Alcohol and obesity are two major causes of …
EASL–EASD–EASO Clinical Practice Guidelines …
www.easl.euEASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver diseaseq European Association for the Study of the Liver (EASL)⇑, European Association for the Study
EASL Clinical Practice Guidelines: The diagnosis and ...
www.easl.euEASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitisq European Association for the Study of the Liver⇑
EASL-ALEH Clinical Practice Guidelines: Non …
www.easl.euEASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis European Association for the Study of the Liver⇑
Related documents
肝細胞惡性腫瘤的經導管動脈化學藥物栓塞治療
depart.femh.org.tw經導管動脈化學藥物栓塞治為影像醫學科醫師主要發展的治療手術之 一，也是一種微創手術，傷口只有直徑兩公釐不到。
BCLC stage C の進行肝細胞癌を対象とした ソラ …
thae.kenkyuukai.jp1 JSTHAECRG (Japan Society of Transcatheter Hepatic Arterial Embolization Clinical Research Group) JSTHAECRG-2013-01 (HCC-Sorafenib+TACEⅡ) BCLC stage C の進行肝細胞癌を対象とした
The 47th Annual Meeting of the Japanese Society of ...
www.congre.co.jpThe 47th Annual Meeting of the Japanese Society of Interventional Radiology Program Day 1 Thursday, May 31 Room 1 (Palais Royal A) 8:20-8:30 Opening Remarks 8:30-9:50 Symposium 1 p000
肝細胞癌サーベイランスアルゴリズム・診断アルゴ …
www.jsh.or.jp肝細胞癌サーベイランスアルゴリズム・診断アルゴリズムの解説. にて行う。超音波での経過観察中，サイズアップを認めた場合は，
第2回肝炎・免疫研究センター 看護師研修会
www.kanen.ncgm.go.jp肝動脈化学塞栓術 Transcatheter arterial chemoembolization 理論正常肝･･･動脈血20～25％ 門脈血75～80％ 肝細胞癌･･･ほとんどが動脈血
第6 章 肝動脈 化学 塞栓療法 TA(C)E CQ37
www.nihon-kangan.jp第6 章 肝動脈(化学)塞栓療法TA(C)E 140 CQ37 TACE/TAE はどのような患者に行うべきか？ 推 奨 腫瘍個数4 個以上，Child 分類のA～B，performance status 0～2 のBCLC Stage B
No.14-06 2014 2 3 - eisai.co.jp
www.eisai.co.jp中心循環系血管内塞栓促進用補綴材「ディーシー ビーズ ®」を日本で新発売. エーザイ株式会社（本社：東京都、社長：内藤晴夫）は、日本において、中心循環系血管内塞栓促進
第5章 肝動脈化学塞栓療法 TACE - jsh.or.jp
www.jsh.or.jp第5章 肝動脈化学塞栓療法tace 137 はじめに いわゆる典型的な多血性肝細胞癌は動脈血で栄養されている。